Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 13.30
  • 52 Week Low: 5.13
  • Currency: UK Pounds
  • Shares Issued: 443.23m
  • Volume: 231,074
  • Market Cap: £43.22m

Latest ShareCast News

Ondine appoints new finance, operations chief

By Josh White

Date: Wednesday 26 Feb 2025

(Sharecast News) - Ondine Biomedical announced the appointment of Michael Behlke as its chief financial and chief operating officer on Wednesday, strengthening its leadership team as the company advanced its commercialisation strategy.

Ondine Biomedical gets $4m investment from HCA Healthcare subsidiary

By Josh White

Date: Monday 27 Jan 2025

(Sharecast News) - Ondine Biomedical announced a $4m equity investment from hInsight-NX, a subsidiary of US medical facilities giant HCA Healthcare, on Monday, extending its cash runway through to the fourth quarter.

Ondine enrols first patient in phase three clinical trial

By Josh White

Date: Monday 30 Dec 2024

(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surgical site infections' (LANTERN) on Monday, having enrolled its first patient.

Ondine enrols first patient in phase three clini... 30-Dec-2024 ShareCast
Ondine Biomedical to start phase three Steriwave... 17-Dec-2024 ShareCast
Ondine raising £8.5m to fund US clinical trial 01-Nov-2024 ShareCast
Ondine Biomedical gets UAE approval for Steriwave 18-Oct-2024 ShareCast
Ondine Biomedical's Steriwave added to NHS Suppl... 21-Jun-2024 ShareCast
Ondine reports significant financial growth 24-Apr-2024 ShareCast
Ondine Biomedical assessing Steriwave with Yorks... 05-Mar-2024 ShareCast
Ondine raises $3.6m to help commercialise Steriw... 13-Dec-2023 ShareCast
Ondine reports strong research findings from Can... 23-Oct-2023 ShareCast
Ondine announces expanded Canadian availability ... 13-Oct-2023 ShareCast
Ondine disinfection tech to be used at another C... 07-Aug-2023 ShareCast
Ondine Biomedical reports first-quarter progress 17-Apr-2023 ShareCast
Ondine Biomedical upbeat on photodisinfection st... 17-Jan-2023 ShareCast
Ondine reports success in MRSA clinical trial 02-Dec-2022 ShareCast
Ondine technology 'highly effective' against MRS... 19-Oct-2022 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 9.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 13.30
52 Week Low 5.13
Volume 231,074
Shares Issued 443.23m
Market Cap £43.22m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.7% below the market average68.7% below the market average68.7% below the market average68.7% below the market average68.7% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
38.62% above the market average38.62% above the market average38.62% above the market average38.62% above the market average38.62% above the market average
67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average
Income Not Available
Growth
33.49% above the market average33.49% above the market average33.49% above the market average33.49% above the market average33.49% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

OBI Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
12:53 30,000 @ 9.53p
09:07 100,000 @ 9.50p
09:03 100,000 @ 9.89p
09:31 100 @ 10.00p
09:27 950 @ 9.89p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page